(19)
(11) EP 1 590 442 A2

(12)

(43) Date of publication:
02.11.2005 Bulletin 2005/44

(21) Application number: 04709020.4

(22) Date of filing: 06.02.2004
(51) International Patent Classification (IPC)7C12N 1/00
(86) International application number:
PCT/US2004/003479
(87) International publication number:
WO 2004/072243 (26.08.2004 Gazette 2004/35)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 07.02.2003 US 360947
13.02.2003 US 365854
07.03.2003 US 384120

(71) Applicant: Enanta Pharmaceuticals, Inc.
Watertown, MA 02472 (US)

(72) Inventors:
  • MIAO, Zenwei
    Medway, MA 02053 (US)
  • SUN, Ying
    Waltham, MA 02451 (US)
  • WU, Frank
    Shrewsbury, MA 01545 (US)
  • NAKAJIMA, Suanne
    Cambridge, MA 02140 (US)
  • XU, Guoyou
    Auburndale, MA 02466 (US)
  • OR, Yat, Sun
    Watertown, MA 02472 (US)
  • WANG, Zhe
    Hockessin, DE 19707 (US)

(74) Representative: Adam, Holger et al
Kraus & Weisert, Patent- und Rechtsanwälte, Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS